Abstract:Chao Wang, 1, &ast Mei Zhao, 2, &ast Yuanyuan Yue, 3 Chao Hu, 2 Chunqiu Zhou, 2 Zhongyi Zhang, 2 Yunliang He, 4 Yaqi Luo, 4 Tao Shen, 2 Sijie Dang, 4 Yang Yang, 4 Yong Zhang 2, 4 1 Traditional Chinese Medicine Department, Qitai Hospital of the Sixth Division, Xinjiang, 831899, People's Republic of China; 2 College of Basic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, People's Republic of China; 3 Department of Ultrasound, Chengdu First People's Hospital, Chengdu, 610095, People's Republic of China; 4 Institute of Traditional Chinese Medicine, Sichuan Academy of Chinese Medicine Sciences, Chengdu, 610014, People's Republic of China &astThese authors contributed equally to this work Correspondence: Yong Zhang; Yang Yang, Institute of Traditional Chinese Medicine, Sichuan Academy of Chinese Medicine Sciences, Chengdu, People's Republic of China, Email ; Background: Modified Suanmei-Tang (MST) comprises four plants common to both traditional Chinese medicine and culinary applications, and it can potentially alleviate metabolic-associated fatty liver disease (MAFLD) triggered by a high-fat diet (HFD). Purpose: This research aims to investigate the impact and underlying mechanisms of MST in ameliorating MAFLD caused by an HFD. Methods: UHPLC-Q-Orbitrap-MS/MS was used to determine the constituents of MST and to evaluate its effects on MAFLD mouse models. Transcriptomics, network pharmacology, and bioinformatics analysis (including Kyoto Encyclopedia of Genes and Genomes and Gene Set Enrichment Analysis) were utilized to further clarify the mechanisms by which MST acts on MAFLD. The experimental methods included ELISA, real time quantitative PCR (RT-qPCR), Western blot, immunohistochemistry, molecular docking, and metabolomics. Transcriptomics was integrated with metabolomics to find correlations between differentially expressed genes and metabolites, and crucial genes were validated through RT-qPCR. Results: A total of 23 components of MST were identified. The formulation was found to alleviate metabolic disorders, obesity, insulin resistance, inflammation, and oxidative stress in mice with MAFLD. The findings indicate that MST promoted autophagy by suppressing phosphorylation in the PI3K/AKT/mTOR pathway and enhancing lipid management in the livers of MAFLD mice. Conclusion: MST could effectively improve lipid metabolism disorders and liver lipid deposition in MAFLD mice, and its mechanism might be related to regulating the PI3K/AKT/mTOR pathway to improve autophagy. Keywords: modified Suanmei-Tang, MAFLD, transcriptomics, network pharmacology, metabolomics Graphical Metabolic-associated fatty liver disease (MAFLD) affects roughly 25% of people worldwide and is a major factor in the development of cirrhosis and liver cancer. 1 However, due to the extremely complex etiology and pathogenesis of MAFLD, there is a lack of targeted pharmaceutical interventions. The multiple-hit hypothesis offers insight into the genesis and advancement of MAFLD, positing that genetically predisposed individuals experience a series of insults, including lipid toxicity, insulin resistance (IR), mitochondrial and endoplasmic reticulum dysfunction, oxidative stress, and disrupted autophagy and inflammasomes. 2,3 Furthermore, numerous research findings have shown that disruptions in liver lysosomes and autophagy are connected to steatosis in MAFLD at the organ and cellular levels, highlighting autophagy as a promising therapeutic target. 4,5 Traditional Chinese medicine (TCM) is characterized by unique therapeutic methods that are vital for promoting health and addressing diseases. TCM formulas typically consist of a combination of herbs that produce synergistic effects, resulting in favorable therapeutic results. Numerous TCM recipes have demonstrated beneficial outcomes in MAFLD cases, specifically by improving lipid metabolism and reducing inflammation, oxidative damage, and cellular death and decay. 6,7 Modified Suanmei-Tang (MST), a well-known traditional Chinese medicine blend, consists of Wumei (Prunus mume [Sieb.] Sieb. et Zuce), Shanzha (Crataegus pinnatifida Bunge), Chenpi (Citrus reticulata Blanco), and Gancao (Glycyrrhiza uralensis Fisch). Modern pharmacology has indicated that Wumei, Chenpi, and Gancao exhibit potent anti-inflammatory and antioxidant properties, thus mitigating tissue damage. 8–10 Additionally, Shanzha has been shown to ameliorate HFD-induced endothelial dysfunction by facilitating lipid expulsi -Abstract Truncated-

A Versatile Ultrafine and Super-Absorptive H+-modified Montmorillonite: Application for Metabolic Syndrome Intervention and Gastric Mucosal Protection.

Treatment of Chronic Atrophy Gastritis of Rats with Montmorillonites from Different Sources

Gualou-Xiebai-Banxia-Tang regulates liver-gut axis to ameliorate Metabolic Syndrome in HFD-fed mice

Multifunctional Nanoparticles with Anti-Inflammatory Effect for Improving Metabolic Syndromes.

Microbiome Remodeling via the Montmorillonite Adsorption-Excretion Axis Prevents Obesity-related Metabolic Disorders.

Chinese herbal extracts (SK0506) as a potential candidate for the therapy of the metabolic syndrome

Heptamethoxyflavone Alleviates Metabolic Syndrome in High-Fat Diet-Fed Mice by Regulating the Composition, Function, and Metabolism of Gut Microbiota

Anti-Metabolic Syndrome Effects of Fucoidan from Fucus vesiculosus via Reactive Oxygen Species-Mediated Regulation of JNK, Akt, and AMPK Signaling

Prevention of Obesity and Hyperlipidemia by Heptamethoxyflavone in High-fat Diet-induced Rats.

Effectiveness of a Food Supplement Based on Glucomannan, D-Chiro-Inositol, Cinnamomum zeylanicum Blume and Inulin in Patients with Metabolic Syndrome

The Regulation Effect of Crude Polysaccharides from Cordyceps Militaris on Obesity Control and Gut Microbiota Community via High-Fat Diet-Fed Mice Model

Protective Effect of Modified Suanmei-Tang on Metabolic-Associated Fatty Liver Disease: An Integrated Strategy of Network Pharmacology, Metabolomics, and Transcriptomics

Low molecular weight fucoidan fraction LF2 improves metabolic syndrome via up-regulating PI3K-AKT-mTOR axis and increasing the abundance of Akkermansia muciniphila in the gut microbiota

Nanocapsule-mediated sustained H2 release in the gut ameliorates metabolic dysfunction-associated fatty liver disease

Shengmai San formula alleviates high-fat diet-induced obesity in mice through gut microbiota-derived bile acid promotion of M2 macrophage polarization and thermogenesis

Gut microbiota combined with serum metabolites to reveal the effect of Morchella esculenta polysaccharides on lipid metabolism disordered in high-fat diet mice

2', 3', 5'-tri-O-acetyl-N6-(3-hydroxyphenyl) adenosine alleviates diet-induced hyperlipidemia by modulating intestinal gene expression profiles and metabolic pathway

Anti-Hyperlipidemia and Gut Microbiota Community Regulation Effects of Selenium-Rich Cordyceps militaris Polysaccharides on the High-Fat Diet-Fed Mice Model

Amelioration of high-fat diet-induced obesity and its associated complications by a myricetin derivative-rich fraction from Syzygium malaccense in C57BL/6J mice

Metabolic Syndrome Ameliorated by 4-Methylesculetin by Reducing Hepatic Lipid Accumulation

Massa Medicata Fermentata, a Functional Food for Improving the Metabolic Profile via Prominent Anti-Oxidative and Anti-Inflammatory Effects